drugset / Trial / NCT03175913

Vapocoolant Spray for Reducing the Pain of Spinal Needle Insertion

NCT03175913 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

This was a single-blind, randomized controlled trial. Sixty-six patients who underwent caudal epidural injection were randomized into the vapocoolant spray group or local infiltration group. Before the insertion of a 20-gauge spinal needle, the subcutaneous tissue was infiltrated with 3 ml of 2% lidocaine in the local infiltration group and vapocoolant spray was applied just before the spinal needle insertion in the spray group. 100-mm visual analog scale to evaluate the pain intensity of spinal needle insertion and a five-point Likert scale for patient satisfaction and preference for repeated use were compared between the two groups.

Timeline

Start
2014-06-01
Primary completion
2015-12-01
Completion
2015-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Lidocaine Other / unclassified 2 % Subcutaneous
Subject Lidocaine Other / unclassified 3 ml Subcutaneous

Indications

No indication recorded.